Evidence map›Paper›PMID 38855664›Full record

ArticleBiomedical optics express2024

Theoretical impact of chromatic aberration correction on visual acuity.

Derek Nankivil, Nicolas P Cottaris, David H Brainard

Abstract read
In one paragraph

Article in Biomedical optics express, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Basic Optics Underlying Current Intraocular Lenses.Journal of clinical medicine · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Derek NankivilJohnson & Johnson Vision Care Inc., Research & Development, 7500 Centurion Parkway, Jacksonville, FL 32256, USA.
Nicolas P CottarisDepartment of Psychology, University of Pennsylvania, Goddard Laboratories, Philadelphia, PA 19104, USA.
David H BrainardDepartment of Psychology, University of Pennsylvania, Goddard Laboratories, Philadelphia, PA 19104, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been known for more than 220 years that the image quality of the human eye is significantly degraded by chromatic aberrations. Recently, it was shown experimentally that correcting chromatic aberrations results in a 0.2- to 0.8-line improvement in visual acuity. Here we ask, is this expected? We developed tools that enable simulations of the optical impact of physiologically relevant amounts of chromatic aberration in real human eyes and combined these with tools that compute the visual acuity of an ideal observer. This allows us to characterize the theoretical impact of chromatic aberration correction on visual acuity. Results indicate a substantive improvement of 0.4- to 2-lines in ideal observer visual acuity with chromatic aberration correction. Ideal observer thresholds benefit significantly more from correction of longitudinal than correction of transverse chromatic aberration. Finally, improvements in ideal observer visual acuity are greater for subjects with less monochromatic aberration, such that subjects with better baseline optical quality benefit most from correction of chromatic aberrations.

Identifiers

PMID38855664
PMCPMC11161344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.